Updates in the Diagnosis of Gestational Trophoblast Disease

GTD (Gestational Trophoblastic Disease) is a pathology that encompasses benign and malignant clinical forms, affects women of childbearing age, has variable incidence more frequent in developing or underdeveloped countries, colliding with the economic barrier. The absence clear protocols guidelines for correct diagnosis results inadequate classification, imprecise treatment failed post-therapeutic observation, increasing risk relapses, morbidity mortality. present study aims to point out updated national international practice GTD, through an integrative review. Seven articles were selected it was observed main reference centers are agreed management suggested by IFGO (International Federation Gynecology Obstetrics), being conduct Hydatidiform Mole (HM): evacuation suction curettage under ultrasound guidance, followed hCG monitoring every 1 - 2 weeks until normalized (usually one month Partial six months Complete year Gestational Neoplasia). Unfortunately, regarding MH, some countries show difficulty access karyotype test ploid p57 pelvic accompanying uterine curettage, contrary what proposed guideline. Establishing complying consistent can improve patient care, early its complications, reducing rate recurrence, mortality, especially less developed countries.